One in four people experience mild side effects from Covishield vaccine: Lancet study

Updated:
Systemic effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea.
Share Article
AAA
Covishield vaccine vial at the COVID-19 vaccination centre in Coimbatore on Tuesday April 27, 2021.   | Photo Credit: PERIASAMY M
Systemic effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea.
One in four people experience mild, short lived systemic side effects after receiving the COVID-19 preventive by Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccine — known as Covishield in India — with headache, fatigue and tenderness the most common symptoms, according to a study published in the
Lancet Infectious Diseases journal.
The researchers from King's College London in the U.K. also found that most systemic side effects — meaning side effects excluding where the injection took place — peaked within the first 24 hours following vaccination and usually lasted 1-2 days.

Related Keywords

London ,City Of ,United Kingdom ,India ,Oxford Astrazeneca Chadox ,Tim Spector ,King College London ,Pfizer ,Astrazeneca ,Professor At King College London ,Lancet Infectious Diseases ,College London ,Professor Tim Spector ,Corona Virus ,Vaccine ,Vaccine Side Effect ,Pfizer Biontech ,Oxford Astrazeneca ,Covid 19 Vaccines ,லண்டன் ,நகரம் ஆஃப் ,ஒன்றுபட்டது கிஂக்டம் ,இந்தியா ,நேரம் ஸ்பெக்டர் ,கிங் கல்லூரி லண்டன் ,ஃபைசர் ,ப்ரொஃபெஸர் இல் கிங் கல்லூரி லண்டன் ,கல்லூரி லண்டன் ,ப்ரொஃபெஸர் நேரம் ஸ்பெக்டர் ,கொரோனா வைரஸ் ,தடுப்பூசி ,தடுப்பூசி பக்க விளைவு ,